Skip to content
DataLookout
Menu

ACCESSNCT06730555

Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)

StatusActive, Not Recruiting
PhaseNot applicable
Primary completion (estimated)
Track this trial

Free. We email you which fields changed when ClinicalTrials.gov updates this record.

Record History

All 7 versions: 7 with changes below. See every version on ClinicalTrials.gov ↗

  1. Notable Eligibility criteria expanded, about 10 words Show 4 more changesShow less
    • Enrollment closed, study ongoing
    • Final enrollment: 36 participants (planned 40)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site details revised
  2. Minor Enrollment target: 32 to 40
    • Site contact updated
    v6
  3. Notable Primary endpoints revised (2)
    • Secondary endpoints: details revised at 1 of 1 entry
    • Site contact updated
    v5
  4. Notable Eligibility criteria expanded, about 5 wordsv4
  5. Notable Trial status: Not Yet Recruiting to Recruitingv3 Show 4 more changesShow less
    • Start date changed from estimate of Aug 1, 2025 to Jun 27, 2025
    • Secondary endpoints: 3 to 1
    • Site details revised
    • Study title shortened, about 1 word
  6. Notable Primary endpoints: 1 to 2
    • Site contact updated
    v2
  7. Study First Submitted
  • Notable: the plan changed
  • Minor: routine updates

Endpoints

Primary

Number of SSP participants reached
Timeframe: up to 18 months
Adoption
Timeframe: up to 6 months

Secondary (1)

Number of SSP participants reached after the intervention

Arms and interventions

ACCESS GroupExperimental

Participants in this group will receive the ACCESS intervention for up to 18 months

Control GroupActive comparator

Participants in this group will receive a link to the CDC Compendium of Evidence-Based Interventions for up to 18 months.

Behavioral: ACCESS Intervention, Control Group

Sites

1 site in 1 country

  • University of MiamiMiami, Florida, United States